% Expired Patents = 50.0

EPO Patents = 1

Trademarks = 3

Forward Citations = 27

Loading Chart...

4 inventors (with patents filed for the assignee):

Carter R Anderson (4 out of 32 patents)

Russell L Morris (4 out of 28 patents)

Robert Cohen (2 out of 6 patents)

4. Walter L Sembrowich (1 out of 4 patents)

5. Lori A Grace (2 patents)

6. Clayton J Anderson (1 patent)

4 patents: Sort by Forward Citations

1. 7904146 - Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions (2011-03-08),

2. 7867511 - Abuse potential reduction in abusable substance dosage form (2011-01-11),

3. 7856263 - Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis (2010-12-21),

4. 7844327 - Dosage control electrode for iontophoresis device (2010-11-30),

Company Overview

Travanti Pharma Inc. is a leading pharmaceutical company specializing in the development and distribution of innovative healthcare products. With a focus on research and development, Travanti Pharma Inc. strives to bring cutting-edge solutions to improve patient outcomes and quality of life. Through strategic partnerships and a commitment to excellence, Travanti Pharma Inc. is dedicated to making a positive impact on global health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#16 in Mendota Heights, MN

#1,651 in Minnesota

#60,641 in US

Mendota Heights, MN, United States of America

Travanti Pharma Inc.

Forward Citations = 27

4 inventors:

Carter R Anderson (4 out of 32 patents)

Russell L Morris (4 out of 28 patents)

Robert Cohen (2 out of 6 patents)

4. Walter L Sembrowich (1 out of 4 patents)

5. Lori A Grace (2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Travanti Pharma Inc.. Retrieved from https://idiyas.com/company/travanti-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]